APA (7th ed.) Citation

Shovman, O., Gilburd, B., Chayat, C., Lazar, A. D., Amital, H., Blank, M., . . . Shoenfeld, Y. (2017). Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Immunologic research, 65(1), 276-281. https://doi.org/10.1007/s12026-016-8867-x

Chicago Style (17th ed.) Citation

Shovman, O., B. Gilburd, C. Chayat, A. Dortort Lazar, H. Amital, M. Blank, C. Bentow, M. Mahler, and Y. Shoenfeld. "Anti-HMGCR Antibodies Demonstrate High Diagnostic Value in the Diagnosis of Immune-mediated Necrotizing Myopathy Following Statin Exposure." Immunologic Research 65, no. 1 (2017): 276-281. https://doi.org/10.1007/s12026-016-8867-x.

MLA (9th ed.) Citation

Shovman, O., et al. "Anti-HMGCR Antibodies Demonstrate High Diagnostic Value in the Diagnosis of Immune-mediated Necrotizing Myopathy Following Statin Exposure." Immunologic Research, vol. 65, no. 1, 2017, pp. 276-281, https://doi.org/10.1007/s12026-016-8867-x.